Fractyl Health's REMAIN-1 study meets six-month co-primary endpoint

Fractyl Health's REMAIN-1 pivotal study met its six-month co-primary endpoint with high statistical significance, demonstrating 80% retention of GLP-1 induced weight loss versus 67% for sham.

Detected & updated continuously · Source: Nebula